Articles by Daniel Marsh
BofA Turns Bearish on Salesforce, Flags AI Risk to Growth Model
BofA Securities reinstated Salesforce with an Underperform rating and $160 target, citing AI risks to its growth model. Shares rose despite the bearish note.
Quince Therapeutics Faces Nasdaq Listing Uncertainty Amid Going Concern Warning
Quince Therapeutics stock trades near $1.15 as the company faces Nasdaq compliance issues, a going concern warning, and a failed Phase 3 trial, with a shareholder vote on a reverse stock split scheduled for June 11.
Berkshire Hathaway Takes Stake in Macy's; Stock Rises in Pre-Market
Berkshire Hathaway's new 3.04 million share stake in Macy's, valued at $55 million, lifted shares in pre-market. Q1 results are due June 3, with headwinds from tariffs and weak spending.
Virax Biolabs Surges on TV Segment and Ownership Filing
Virax Biolabs shares surged over 125% in pre-market trading Monday after a sponsored TV segment featuring its CEO and a new SEC filing revealed Armistice Capital holds a 4.99% stake.
Hims & Hers Shares Slide on Convertible Note Sale, Dilution Worries
Hims & Hers Health shares declined 4% in pre-market trading after announcing a $300 million convertible note sale to finance its Eucalyptus acquisition and technology investments.
Huachen AI Parking Surges 82% Premarket on Nasdaq Compliance Hopes
Huachen AI Parking Management shares jumped 82% in premarket trading Monday, driven by Nasdaq compliance buzz and a recent reverse stock split. The stock reached $10.10 with volumes far above average.
T1 Energy Rises Premarket as Shareholder Vote on Capital Hike Nears
T1 Energy Inc. stock traded up to $6.56 premarket Monday after closing at $5.67 Friday, as the company seeks shareholder approval to double authorized shares to 1 billion for its G2_Austin solar cell plant.
AI Data Center Boom Drives $66.8B NextEra-Dominion Merger
NextEra Energy is buying Dominion Energy for $66.8 billion in stock, forming the largest regulated electric utility globally to power AI data centers.
GeoVax Shares Surge Pre-Market on Mpox Vaccine Trial Plans
GeoVax Labs shares surged pre-market Monday after announcing plans for a Phase 3 trial of its GEO-MVA mpox vaccine, though cash and funding risks remain key issues.
Redwire Stock Holds Steady After 27% Rally, Focus Shifts to Defense Showcase
Redwire shares traded flat Monday after a 27% rally last week, as the market awaits updates from the SOF Week defense event in Tampa and assesses the company's $498.1 million backlog.